The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

DES MOINES — Iowa Gov. Kim Reynolds released her proposal to state lawmakers Friday to ban cell phone use in classrooms. The proposed legislation would require school districts restrict cell phone use ...

Sintilimab plus neoadjuvant CRT improved pathological complete response rates in resectable, locally advanced ESCC, per phase ...

The six were among 40 finalists nationwide in the Regeneron Science Talent Search, the country's most prestigious science research competition.

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

After transitioning from a Math specialization to English, a Vietnamese student has secured an 80% scholarship worth ...

The board discussed new science textbooks, a tentative facilities budget and the debate on cell phone use in schools at its ...

According to precedent and due to his status, Yoon will probably be assigned a solitary cell, likely bigger and better appointed than the standard 6.56 square metre (71 square feet) single cells.

This innovative therapy promotes natural hair growth by purifying the scalp, removing dirt, oil, and dead skin cells, stimulating circulation ... he recommends products from Skinbetter Science, ZO ...